Product Information
CLOBAZAM 2.5 MG/ML SUSPENSION is a generic product labeled by Taro Pharmaceuticals U.S.A. Inc., priced at $0.1687 per ML under NDC 51672422708. Its NADAC has been published 252 times since Oct 27, 2021.
FDA first approved this application on Apr 15, 2019. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
2.5 mg/mL
Manufacturer
Taro Pharmaceuticals U.S.A. Inc.NDC
51672422708
Classification
Generic
Dosage Form
SUSPENSION
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
CLOBAZAMApproval Type
Generic (ANDA)
FDA Application
ANDA210978FDA Approved
4/15/2019
TE Code
AB
On Market Since
6/30/2021
Pharmacological Classes
Price Statistics
The NADAC for CLOBAZAM 2.5 MG/ML SUSPENSION has been published 252 times since Oct 27, 2021, and over the history we have for it it has declined 62.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1687 per ML |
|---|---|
| All-time high | $0.6119 (Dec 15, 2021) |
| All-time low | $0.1530 (May 20, 2026) |
| 52-week high | $0.1928 |
| 52-week low | $0.1530 |
| Median price | $0.2310 |
| Average price | $0.2744 |
| Largest weekly change | +35.6% (Nov 17, 2021) |
| Weeks tracked | 252 |
| Tracking since | Oct 27, 2021 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of CLOBAZAM 2.5 MG/ML SUSPENSION?
The current National Average Drug Acquisition Cost (NADAC) for CLOBAZAM 2.5 MG/ML SUSPENSION, manufactured by Taro Pharmaceuticals U.S.A. Inc., is $0.1687 per ML (NDC 51672422708), effective Aug 19, 2026.
How has the price of CLOBAZAM 2.5 MG/ML SUSPENSION changed over time?
Over the history we have for it, the NADAC for CLOBAZAM 2.5 MG/ML SUSPENSION has declined 62.6%. It has been tracked across 252 weekly CMS publications since Oct 27, 2021.
What are the highest and lowest recorded NADAC prices for CLOBAZAM 2.5 MG/ML SUSPENSION?
Since Oct 27, 2021, the NADAC for CLOBAZAM 2.5 MG/ML SUSPENSION has ranged from a low of $0.1530 (May 20, 2026) to a high of $0.6119 (Dec 15, 2021), with a median of $0.2310 per ML.
Are there cheaper alternatives to CLOBAZAM 2.5 MG/ML SUSPENSION?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as CLOBAZAM 2.5 MG/ML SUSPENSION in a comparable dosage form, but none are currently priced below it.
Who manufactures CLOBAZAM 2.5 MG/ML SUSPENSION?
CLOBAZAM 2.5 MG/ML SUSPENSION (NDC 51672422708) is labeled by Taro Pharmaceuticals U.S.A. Inc., and CMS classifies it as a generic product.